Medidata Solutions, Inc. (MDSO) Downgraded by BidaskClub

BidaskClub cut shares of Medidata Solutions, Inc. (NASDAQ:MDSO) from a buy rating to a hold rating in a report published on Wednesday.

Other equities analysts have also issued research reports about the stock. Bank of America Corporation began coverage on shares of Medidata Solutions in a report on Tuesday, June 6th. They set a buy rating and a $85.00 price target on the stock. Needham & Company LLC boosted their target price on shares of Medidata Solutions from $65.00 to $75.00 and gave the company a buy rating in a report on Thursday, April 27th. Zacks Investment Research upgraded shares of Medidata Solutions from a hold rating to a buy rating and set a $75.00 target price on the stock in a report on Wednesday, May 3rd. Jefferies Group LLC upgraded shares of Medidata Solutions from an underperform rating to a hold rating and set a $46.00 target price on the stock in a report on Friday, April 28th. Finally, KeyCorp boosted their target price on shares of Medidata Solutions from $71.00 to $74.00 and gave the company an overweight rating in a report on Thursday, May 11th. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock currently has a consensus rating of Buy and a consensus price target of $69.40.

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Medidata Solutions (NASDAQ MDSO) opened at 76.8393 on Wednesday. Medidata Solutions has a 1-year low of $41.65 and a 1-year high of $80.70. The stock has a 50 day moving average price of $71.53 and a 200-day moving average price of $59.08. The firm has a market cap of $4.33 billion, a P/E ratio of 130.4572 and a beta of 1.86.

Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Wednesday, April 26th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.20. The company had revenue of $126.80 million for the quarter, compared to analyst estimates of $125.90 million. Medidata Solutions had a net margin of 6.72% and a return on equity of 11.05%. Medidata Solutions’s revenue was up 21.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.25 earnings per share. Equities research analysts forecast that Medidata Solutions will post $1.29 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Medidata Solutions, Inc. (MDSO) Downgraded by BidaskClub” was posted by Mideast Time and is owned by of Mideast Time. If you are reading this news story on another site, it was stolen and reposted in violation of US and international copyright and trademark laws. The original version of this news story can be viewed at https://www.mideasttime.com/medidata-solutions-inc-mdso-downgraded-by-bidaskclub/1792174.html.

In other news, CEO Tarek Sherif sold 2,964 shares of the business’s stock in a transaction dated Tuesday, April 4th. The shares were sold at an average price of $57.08, for a total transaction of $169,185.12. Following the completion of the sale, the chief executive officer now directly owns 815,356 shares of the company’s stock, valued at $46,540,520.48. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Michael L. Capone sold 5,000 shares of the business’s stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $69.46, for a total transaction of $347,300.00. Following the sale, the chief operating officer now directly owns 171,754 shares of the company’s stock, valued at $11,930,032.84. The disclosure for this sale can be found here. Insiders have sold 21,103 shares of company stock worth $1,428,651 in the last quarter. Company insiders own 6.70% of the company’s stock.

Large investors have recently bought and sold shares of the company. FMR LLC increased its stake in Medidata Solutions by 12.3% in the fourth quarter. FMR LLC now owns 7,576,918 shares of the company’s stock valued at $376,345,000 after buying an additional 830,073 shares during the last quarter. Brown Capital Management LLC increased its stake in shares of Medidata Solutions by 0.6% in the first quarter. Brown Capital Management LLC now owns 5,921,818 shares of the company’s stock worth $341,630,000 after buying an additional 33,042 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Medidata Solutions by 5.1% in the first quarter. Vanguard Group Inc. now owns 4,874,974 shares of the company’s stock worth $281,237,000 after buying an additional 235,190 shares during the last quarter. Clearbridge Investments LLC increased its stake in shares of Medidata Solutions by 61.4% in the first quarter. Clearbridge Investments LLC now owns 2,449,038 shares of the company’s stock worth $141,285,000 after buying an additional 931,729 shares during the last quarter. Finally, Champlain Investment Partners LLC increased its stake in shares of Medidata Solutions by 11.5% in the first quarter. Champlain Investment Partners LLC now owns 1,653,230 shares of the company’s stock worth $95,375,000 after buying an additional 169,870 shares during the last quarter. 99.66% of the stock is owned by institutional investors.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:MDSO”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.